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Cost effectiveness analyses (CEAs) are widely used to evaluate the opportunity cost of
health care investments. However, few functions that take equity concerns into account are
available for such CEA methods, and these concerns are therefore at risk of being disre-
garded. Among the functions that have been developed, most focus on the distribution of
health gains, as opposed to the distribution of lifetime health. This is despite the fact that
there are good reasons to give higher priority to individuals and groups with a low quality
adjusted life expectancy from birth (QALE). Also, an even distribution of health gains may
imply an uneven distribution of lifetime health.
Methods
We develop a systematic and explicit approach that allows for the inclusion of lifetime health
concerns in CEAs, by creating a new priority weight function, PW = α+(t-γ)�C�e-β�(t-γ), where t
is the health measure. PW has several desirable properties. First, it is continuous and
smooth, ensuring that people with similar health characteristics are treated alike. For exam-
ple, those who achieve 50 QALE should be treated similarly to those who achieve 49.9
QALE. Second, it is flexible regarding shape and outcome measure (i.e., caters to other
measures than QALE), so that a broad range of values may be modelled. Third, the coeffi-
cients have distinct roles. This allows for the easy manipulation of the PW’s shape. In order
to demonstrate how PW may be applied, we use data from a previous study and estimated
the coefficients of PW based on two approaches.
Conclusions
Equity concerns are important when conducting CEAs, which means that suitable PWs
should be developed. We do not intend to determine which PW is the most appropriate, but
to illustrate how a flexible general PW can be estimated based on empirical data.
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Prioritisation of limited health care resources involves saying no and yes, hard ethical prob-
lems and reasonable disagreements. In health economics, cost-effectiveness analysis (CEA) is
used to identify the most efficient allocation of health care resources. Within such a frame-
work, informed decisions based on explicit CEA rankings can be made. However, CEAs have
been extensively criticised for not being sensitive to fair distribution of health benefits, and
there are other important equity concerns which may be considered, and few standardised
methods are available to directly adjust incremental cost-effectiveness ratios (ICERs) [1–3].
CEAs are used to inform policy decisions on the introduction or reimbursement of new tech-
nologies or pharmaceuticals in countries such as the UK, Norway, Sweden, the Netherlands,
New Zealand and Australia, in some cases including considerations beyond CEA through con-
cepts like severity or burden of disease [4–14].
Typical health metrics in CEAs are quality-adjusted life years (QALYs) gained and disabil-
ity-adjusted life years (DALYs) averted [15]. These aggregate measures take into consideration
not only the life expectancy (LE) of a group, but also the quality of life. Interventions and
health programs are typically ranked by ICERs, where those that maximize QALYs gained or
DALYs averted are favoured. However, such rank-orders of interventions based on ICERs
have been criticized because they disregard concerns for those who are worst off [16]. There
are good reasons to give higher priority to individuals and groups with impaired health [16].
As opposed to health maximisation, one could aim for equal distribution of health across all
individuals in society. This would require that resources should always be directed at people
with the most impaired health, so as to minimize inequality in health outcomes, even if this
means that the total health in the population will be reduced. People’s intuition about what is
fair may lie somewhere between strict health maximisation and strict equality. A compromise
between these perspectives is that health maximization is an important goal, but health gains
to people with impaired health are assigned more weight than similar gains to people with bet-
ter initial health [17]. This “in between” position is called prioritarianism and has been
defended by the philosophers like Derek Parfit [18] and Matthew Adler [19]. According to
prioritarianism, a cheap and effective intervention directed at the healthiest may be preferred
to an expensive and ineffective intervention directed at those who have worse health if left
untreated. Still, if cost and effect were equal, the allocation of resources should be directed
towards people with more impaired health if left untreated. Finally, when comparing compet-
ing health programs, studies have found that people favor priority to worse off, and they favor
interventions that benefit those that are worse off over slightly more cost-effective interven-
tions that benefit better off groups [20, 21]. Such equity concerns are too important to leave
out from standard CEAs.
One may also argue that non-health concerns, like age, indirect benefits, productivity, and
financial risk protection, are also important regarding equity. However, this paper focuses on
health related concerns. At the time of a prospective health intervention, concerns for health
distribution can be roughly divided into two perspectives: The first perspective is forward
looking and is only concerned with the distribution of the health gains, typically measured in
QALYs or DALYs. E.g., one may think that one QALY gained for 50 people is better, equal or
worse than 50 QALYs gained for one individual. The second perspective is dealing with the
distribution of health over a lifetime, often measured as quality adjusted life expectancy from
birth (QALE) [22, 23]. E.g., consider two individuals who may benefit from some treatment.
One has QALE = 80 without treatment and 81 with, and the other has QALE = 20 without
treatment and 21 with. Their gains would be equal, but the second is expected to get much less
lifetime health. Hence, if an equal distribution of lifetime health in the population is a priority,
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one would value the set {80, 21} above {81, 20}. The view that expected lifetime health is
what matters draws support from the literature on health priorities and some empirical
studies [24–28]. Note that although QALE often increases with age, a high age does not nec-
essarily correspond to a high QALE. E.g., the QALE of an old person who has experienced
decades of chronic illness may be far less than that of a healthy child. In other words, cur-
rent age is not a good measure of QALE, and weights based on age are therefore different
than weights based on lifetime health. In this paper we focus on applications of the lifetime
health perspective.
Our aim is the development of a systematic and explicit approach to empirically include
these equity concerns in the framework of CEAs, by creating a new priority weight function.
The function should be smooth and continuous in order to treat people with similar character-
istics alike. Further, it should be flexible regarding shape and outcome measure (e.g., cater to
other measures than QALE) to be able to encompass a broad range of values. Finally, coeffi-
cients should have distinct roles, to ensure that different functions can be easily compared, and
allow for easy manipulation of the function’s shape.
Methods
Moving from utility curves to priority weights
A social welfare function (SWF) is a function that represents the sacrifices that society is will-
ing to make to promote a more equitable health distribution. The input should be a health dis-
tribution (individual QALYs, DALYs, etc.), and the output should be a real number, so that
different distributions can be easily ranked. An SWF incorporates trade-offs between total
health gain and health inequality in a population. Well-known SWFs are the Gini index and
the Atkinson index [29, 30]. Both include a parameter that indicates the degree of inequality
aversion, ranging from 0 to infinite. Such SWFs are data hungry, because complete data about
the health or health gains for an entire population are needed. Often the data required do not
even exist. A different set of SWFs is the one based on the aggregated QALY model. These util-
itarian SWFs have the form
Wðt1; . . . ; tnÞ ¼
Pn
i¼1uðtiÞ; ð1Þ
where ti is the number of QALYs received by individual i (i = 1,. . .,n), and the utility function u
(t), defined over ti, is positive and monotonously increasing (u(t)�0, du/dt>0). If u(t) is concave
(d2u/dt2<0), W represents societal preferences for equality. Equality indifference yields u(t) = t,
and reduces W to be the sum of the QALYs received across all individuals in society. Finally, if u
(t) is convex (d2u/dt2>0), society is assumed to prefer inequality. The function u(t) has been the
focus of several papers [29, 31–34]. As opposed to the Gini and Atkinson indexes, calculating u
(t) does not require complete information about the health or health gains of an entire popula-
tion (t1,. . .,tn). We refer to Rodriguez and Pinto for a more detailed discussion on u(t) [34].
However, u(t) does not account for the distribution of lifetime health. We approach this
problem by considering priority weight functions (PWs) instead. These are functions that
adjust the weight of health gains according to health related equity concerns, such as health
achievement in a lifetime perspective. A general form of an SFW based on PWs is
Wðs1; . . . ; sn; t1; . . . ; tnÞ ¼
Pn
i¼1Fðsi; tiÞ;
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The vertical bars denote that the absolute value is to be considered, and x is a dummy vari-
able used for integration. As an example of how (2) may be calculated, consider a sick individ-
ual with a health level without intervention of QALE = 60, and an intervention with a gain of 3




Although the literature is lacking, one candidate for PW is the age-weight function of the
Global burden of disease (GBD),
PWGBDðtiÞ ¼ C � tie
  bti : ð3Þ
Here ti is the age of individual i [35]. As mentioned, age weights are beyond the scope of
this paper. Still, by letting ti denote the health gain or lifetime health of individual i, (3)
becomes a PW with quite an appealing form, although lacking in flexibility. A lack of flexibility
would also be a problem if one would use a linear PW, such as
PWlinearðtiÞ ¼ aþ b � ti: ð4Þ
Flexibility is an important property of a PW, as it should be able to reflect a wide range of
health related equity concerns. Further, if the coefficients of the PW have distinct roles, they
can easily be adjusted to accommodate such concerns. E.g., one may wish to set an upper limit
for the maximum weight, or set the maximum weight at a fixed value of t. Also, if the PW is fit
to empirical data on people’s preferences, the roles of the coefficients will help to disentangle
different concerns of society. One may, e.g., wish to estimate both the t for which the PW
reaches its maximum, and what the maximum is. This is not straightforward in (3). While
these concerns could be addressed using (4), a linear PW falls short in other aspects. E.g., a
hump is useful if one wants to give lower weights to health gains benefitting those with a very
low QALE (typically children born with severe conditions). If one wishes to do the opposite,
and prioritize health gains to those who are expected to achieve very little lifetime health, PW
may peak at t = 0, and then drop at a faster rate when t is close to 0 than when t is higher. A
PW should also be twice differentiable with respect to t, so that it is continuous (no jumps)
and smooth (no breaking points), ensuring the approximately equal treatment of individuals
with similar values of t.
A priority weight function
In this section we present a new flexible PW with coefficients that have distinct roles, which is
suitable in a lifetime health framework via (2). The formula is as follows:
PW1 ¼ aþ ðt   gÞ � C � e
  b�ðt  gÞ: ð5Þ
Setting α = γ = 0 reduces (5) to (3). Setting C = 0.1658 and β = 0.04 we get the weights
shown in Fig 1A. Panels B and C in Fig 1 show how PW1 can be altered by manipulating C
and β. As seen, C has the effect of inflating or deflating PW1 (Fig 1B). For β>0, it can be shown
that (5) ultimately approaches α with increasing t. We see that for larger β’s this happens more
quickly than for smaller β’s (Fig 1C). When β�0, (5) increases with t, and never approaches α
at all.
The intercept α of (5) shifts the curve up or down (Fig 2A), whereas γ provides a right-left
shift (Fig 2B). As is shown in Fig 2B, it is possible to ensure that the maximum is at t = 0, mak-
ing (5) strictly decreasing. Note that C is interpreted slightly differently for (5) than for (3). For
(5), changing C will affect the relative weights between different values of t unless α = 0. Also,
C�0 is not a problem for (5), because α can be adjusted to make sure that PW1>0 for all
A smooth priority weight formula for CEA
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relevant t’s. A negative C simply causes (5) to be reflected through the line PW1 = α, or in
other words, turned up-side-down. If C = 0, (5) reduces to the line PW1 = α, corresponding to
inequality indifference. This is also true if β approaches infinity.
As demonstrated in Figs 1 and 2, manipulating the different coefficients of (5) allows us to
flexibly change its shape. E.g., if we want to ensure that people with a certain value of t are
given a certain weight (anchoring the curve), we may simply change α. Letting
a ¼ a0   ðA   gÞ � C � e
  b�ðA  gÞ; ð6Þ
anchors the curve to α0 at t = A. Further, if we want to set a maximum weight, so that max
Fig 1. Properties of the coefficients of (5) when α = γ = 0. Panel A: Priority weights according to t. Panel B: Altering C causes an inflation or deflation. Panel C: Altering
β changes the “pointyness” of the hump, causing the peak to become more or less pronounced.
https://doi.org/10.1371/journal.pone.0223866.g001
Fig 2. Properties of the coefficients of (5) when C = 0.1658 and β = 0.04. Panel A: Altering α causes an upward or downward shift. Panel B: Altering γ causes a left or
right shift. Note that one would typically chose a PW where the maximum weight was at zero.
https://doi.org/10.1371/journal.pone.0223866.g002
A smooth priority weight formula for CEA
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(PW1) = wm, we let
C ¼ b � a   wmð Þ �
eb�ðA  gÞ  1
b � ðA   gÞ   eb�ðA  gÞ  1
: ð7Þ
If α0, A, γ, wm and β are given, we can treat (6) and (7) as two linear equations with two
unknowns, and solve for C and α. Fig 3A shows (5) anchored to 1 at t = 80 for different values
of wm.
As mentioned, manipulating γ will shift (5) right or left. It may be of particular interest to
identify the shift needed to ensure that the maximum is moved to t = 0. This means that the
slope is flat at t = 0, and gradually becomes steeper, so that gains for most individuals with
poor lifetime health are given weights close to wm. Differentiating (5) with respect to t, we find
that the maximum is when t = 1/β. Hence, letting γ = −1/β ensures that the maximum is at
t = 0 (Fig 3B). Differentiating (5) once more with respect to t, the t for which the slope is the
steepest can be identified as 2/β. Therefore, letting γ = −2/β causes (5) to be at its steepest when
t = 0. In such a scenario, only gains to people with very poor health are given weights close to
wm (Fig 3B).
Note that although varying α without changing the other coefficients just shifts PW1 up or
down without changing its shape (Fig 2A), fixing the other coefficients in this manner is not
something one would typically do. In order to keep predetermined properties of PW1, such as
anchoring, a change in α would prompt a change in one or more of the other coefficients.
So far the mathematical properties of the coefficients in (5) have been presented, but the
policy implications and conceptual meaning of these properties may not be obvious. The next
paragraphs are dedicated to the discussion of these implications. First, we consider γ. If γ>−1/
β, it is possible that PW(t1)< PW(t2) for t1<t2. This makes sense if one thinks that small gains
to individuals with almost no lifetime health should be worth less than a similar gain to an
individual with more lifetime health. As mentioned, this could pertain to treatment of children
Fig 3. Anchoring to 1 for t = 80, with β = 0.04. Panel A: Varying max t (wm) when γ = 0. Panel B: Varying γ when wm = 2.5. For γ = 0, there is no shift. For γ = −1/β
the curve is shifted left so that the maximum is at t = 0. For γ = −2/β the curve is shifted so that the slope is the steepest at t = 0.
https://doi.org/10.1371/journal.pone.0223866.g003
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born with very severe conditions. In Figs 1 and 2 the default value of γ was 0.04, so that the
maximum was at t = 1/0.04 = 25 QALYs, which is probably too high in most scenarios. When
γ�−1/β, a gain of, e.g., 1 QALY will always be weighted higher for the individual with the least
lifetime health. From now on we shall assume that γ�−1/β.
Next we consider α. The particular value of α is not necessarily easy to interpret, but
because this coefficient allows for the anchoring of the PW at a certain weight for a certain
value of t, it is useful when selecting a reference value of t for which PW = 1 (e.g., one may
anchor PW at 1 when QALE = 70). Once a reference is chosen, the interpretation of the other
coefficients is easier. A large β corresponds to a narrow peak of the PW, ensuring a steep
decline of the curve when t is close to 0. Now, gains to individuals with little lifetime health are
given much higher weights than gains to individuals with more lifetime health, whereas gains
to individuals with intermediate and high levels of lifetime health will be weighted similarly. A
small β yields a flat peak, so that the weight drops steadily as the initial health level improves (t
increases). Although β also will affect the range of possible weights, this property is more
closely connected to the C. The choice of C decides how much value will be assigned to a given
t relative to the reference. E.g., one may think that the maximum weight should be no more
than three times the weight of the reference. A very small C would ensure that all health gains
were treated almost the same.
Application of the priority weight function to experimental data
In order to illustrate the potential use of (5) in a CEA within a lifetime health framework, we
fit the function to data from a convenience sample. The procedure involves two conceptually
simple steps. First, data must be collected, and then the curve must be fit. However, both these
steps may be performed a number of different ways. We shall focus on an approach that is suit-
able for a dataset presented in Ottersen et al. (2014).
Ottersen et al. used a computer based questionnaire to ask 96 students in Norway how they
valued QALYs gained for people at different initial health levels, measured in “initial QALE”
(QALE without intervention). The reference case was a group of healthy people with
QALE = 70 who were subject to an intervention that would give them 10 extra QALYs (i.e.,
move from QALE = 70 to QALE = 80). Respondents were asked to assign QALYs to individu-
als with worse initial health (QALEs in the set {10, 25, 40, 55}) in such a way that they were
indifferent between the different scenarios. Now, priority weights could be calculated for each
individual respondent based on the ratio between the QALYs assigned to the unhealthy groups
and the reference group. E.g., consider a respondent who was indifferent between a situation
where the group with initial QALE = 25 gained 5 QALYs (i.e., moving from 25 to 30) and the
reference group gained 10 QALYs (i.e., moving from 70 to 80). This would mean that gains in
the group with a worse initial health, where initial QALE = 25, are regarded as more important
than gains in the healthy group, where initial QALE = 70. Mathematically, this extra weight
can be expressed as V(25) = 10/5 = 2 relative to the reference group (QALE = 70). We refer to
Ottersen et al. for a more thorough discussion of data and study design.
One may organize the data as follows. Two lists, V and T, are constructed. V contains all
the weights assigned by the respondents, and T contains the initial QALEs, so that the weight
Vi corresponds to the QALE Ti. For purposes of estimating the coefficients of (5), we treat the
observations as independent. Applying a least squares approach, we get that the sum of
squared errors (SSE) is
SSE ¼
P
iðVi   aþ ðTi   gÞ � C � e
  b�ðTi   gÞÞ
2
: ð8Þ
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If one wishes to anchor the curve to a specific value (e.g., the data from Ottersen et al. has V
(70) = 1), it is straightforward to use (6) in (8). Setting maximum weights would imply using
(7) in (8). Also, any coefficient in (8) may be kept constant.
Minimizing SSE ensures that the curve is fit to the mean V for each T in {10, 25, 40, 55}.
Using the R function optim() to minimize SSE, we get
PWmean ¼   0:42þ ðtþ 22:2Þ � 0:27 � e
  0:031�ðtþ22:2Þ: ð9Þ
However, minimizing instead the sum of absolute errors,
SAE ¼
P
ijVi   aþ ðTi   gÞ � C � e
  b�ðTi   gÞj; ð10Þ
the curve is fit to the median. Now PW becomes
PWmedian ¼ 0:79þ ðtþ 8:85Þ � 0:17 � e
  0:053�ðtþ8:85Þ: ð11Þ
Note that when fitting the curves, α and γ were set to ensure that PW(10) was the maximum
(i.e., PW(10) = wm) and PW(70) = 1. Fig 4 shows (9) and (11) plotted with the empirical data.
Note that the PWmean is more affected by extreme values than are PWmedian.
Discussion
We have presented a new priority weight function (PW) with key characteristics that are
important in consistent priority setting across patient groups and populations. As demon-
strated, the PW was suitable for CEA in a lifetime health framework. The PW is flexible and
easy to adjust to a broad range of equity considerations by altering a limited number of com-
prehensible parameters, each with its distinct role. We may set the range of priority weights by
modifying C, we may shift the curve upwards or downwards by modifying α, we may shift the
curve left or right by modifying γ and we may set the “pointiness” of the curve by modifying β.
These characteristics make it easy, e.g., to anchor the curve or to set maximum weights. Con-
sidering (9) and (11) (Fig 4), we see that βmedian>βmean, indicating that PWmedian is pointier
than PWmean. By this we mean that for values of QALE around 10, PWmedian decreases at a
faster rate relative to its maximum than does PWmean. As QALE approaches 70, the relative
rate of decrease is greater for PWmean. Further, we have that Cmedian<Cmean, meaning that
PWmean adds more weight to the worse off than does PWmedian.
Drawing the PW by hand would of course be more flexible than using (5). However, we
argue that setting some restrictions for the behaviour of the PW is useful. First, it offers consis-
tency when comparing different curves. Second, the space of possible PWs is limited by (5),
but the major restrictions caused by (5) seem reasonable (smooth and maximum one hump).
Hence, a large number of nonsensical PWs are impossible (discontinuous and multiple
humps).
We did not account for discounting of future health. It is not clear how this would affect
rankings of interventions. A positive discount rate would put different weights on equally
sized gains that were experienced at different times from the start of intervention (e.g., 0.5
QALYs gained immediately is valued higher than 0.1 QALYs gained each year in five years, or
0.5 QALYs five years from now). Hence, interventions with immediate effects would be valued
A smooth priority weight formula for CEA
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over interventions where the benefit occurs in the future. Also, discounting health gains would
give a relatively low priority to those with large gains, who are expected to have less lifetime
health. This is counterintuitive in a lifetime health priority perspective.
A PW could be used theoretically to assess the impact of applying various ethical principles
to rank health interventions, but ideally, the PW should be inferred from data. Although we do
Fig 4. Estimating PW from data. The red line minimizes (8) to estimate a PW based on the means (black +). The coefficients are α = −0.42, γ = −22.2, C = 0.27, and β =
0.031. The pink line minimizes (10) to estimate a PW based on the medians (blue ×). The coefficients are α = 0.79, γ = −8.85, C = 0.17, and β = 0.053. In both scenarios
PW(10) = wm (maximum weight at T = 10) and PW is anchored at PW(70) = 1.
https://doi.org/10.1371/journal.pone.0223866.g004
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give an example of how this can be done, future work includes developing methodology to do
inference about parameter estimates based on empirical data. This would allow for the testing
of differences in preferences between groups. E.g., conditioning on the other variables, one
could test if men and women preferred different values of C (determining the maximum
weight) or γ (determining the t for which the maximum weight was obtained). When an
appropriate PW (or a range of PWs) has been selected, it could be applied to evaluate the
equity impact of different interventions on reduction of mortality or morbidity. Also, work
should be done to include non-health concerns like socioeconomic status and productivity in
the model, and to explore the consequences of priority-weighted CEAs across settings.
In this paper we do not intend to determine which PW is the most appropriate, but rather
to illustrate what can be achieved by a flexible general PW. However, we would like to stress
the fact that a flat PW is also a PW. In other words, there is no such thing as “not using a PW”
in CEA. As illustrated, our framework allows for the estimation of PWs based on empirical
data.
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